TGFβ-activated Asporin interacts with STMN1 to promote prostate cancer docetaxel chemoresistance and metastasis by upregulating the Wnt/β-catenin signaling pathway
Drug Resistance Updates · 2025
DOI: 10.1016/j.drup.2025.101227 ↗Kurz gefasst
Fachartikel in der Zeitschrift Drug Resistance Updates, 2025. Verfasst von Shengdong Ge und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong 510515, PR China; Department of Urology, The Fifth Affilia…. Hauptthemen laut MEDLINE: Docetaxel, Prostatic Neoplasms, Drug Resistance, Neoplasm, Transforming Growth Factor beta. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 58 Literaturangaben. Gefördert von: Natural Science Foundation of Guangdong Province, National Natural Science Foundation of China, National Key Research and Development Program of China.
Abstract (Originalsprache)
AIMS: Prostate cancer (PCa) remains a significant challenge in oncology due to high rates of drug resistance following standard treatment with docetaxel-based chemotherapy. Asporin (ASPN) has been regarded as an oncogene and its upregulation is closely associated with malignant behavior and poor prognosis in multiple cancers. Studies indicated that abnormal activation of the Wnt/β-catenin signaling pathway is prevalent in PCa. This study investigated the important role of ASPN in regulating Wnt/β-catenin signaling pathway in docetaxel resistance and metastasis of PCa. METHODS: The impacts of ASPN on the docetaxel chemoresistance and metastasis of PCa cells were investigated in vitro and in vivo assays. Lastly, the underlying mechanism of ASPN was revealed by Western blot, protein immunocoprecipitation, Immunofluorescence, Immunohistochemical staining, liquid chromatography-mass spectrometry, and rescue experiments. RESULTS: In present study, we reported that ASPN is highly expressed in PCa cells and tissues. Functional and molecular analyses showed that ASPN is activated by TGFβ and interacts with STMN1. ASPN increases the expression of β-catenin and promotes its nuclear accumulation by mediating the activation of the Wnt/β-catenin signaling pathway, thereby enhancing the stemness and epithelial-mesenchymal transition (EMT) of PCa cells, ultimately facilitating the docetaxel resistance and metastasis of PCa cells. CONCLUSIONS: Our findings identify ASPN as a novel upstream regulatory factor of Wnt/β-catenin signaling pathway, suggesting that targeting the ASPN/STMN1/β-catenin axis could be a promising strategy for PCa intervention.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Urology, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong 510515, PR China; Department of Urology, The Fifth Affiliated Hospital, Southern Medical University, Guangzhou 510900, China.
- Department of Urology, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong 510515, PR China.
- Department of Urology, The Fifth Affiliated Hospital, Southern Medical University, Guangzhou 510900, China.
- Department of Urology, Xiang'an Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, Fujian 361101, PR China.
- Department of Rehabilitation Medicine, The First Affiliated Hospital of Jinan University, Guangzhou, Guangdong 510632, PR China.
- Department of Urology, The First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan 650032, PR China.
Förderung
- Natural Science Foundation of Guangdong Province
- National Natural Science Foundation of China
- National Key Research and Development Program of China
- Southern Medical University
- China Postdoctoral Science Foundation
Zitieren
APA
Ge, S., Cen, J., Liu, X., Hong, Y., Tang, Y., Yu, Y., Li, H., Xie, T., Wang, C., Cai, M., Qiu, Y., Zeng, X., Peng, T., Li, Q., Li, Q., Wu, X., Song, X. L., & Zhao, S. C. (2025). TGFβ-activated Asporin interacts with STMN1 to promote prostate cancer docetaxel chemoresistance and metastasis by upregulating the Wnt/β-catenin signaling pathway. Drug Resistance Updates. https://doi.org/10.1016/j.drup.2025.101227
Vancouver
Ge S, Cen J, Liu X, Hong Y, Tang Y, Yu Y, et al. TGFβ-activated Asporin interacts with STMN1 to promote prostate cancer docetaxel chemoresistance and metastasis by upregulating the Wnt/β-catenin signaling pathway. Drug Resistance Updates. 2025. doi:10.1016/j.drup.2025.101227
BibTeX
@article{Ge2025,
author = {Ge, Shengdong and Cen, Jinpeng and Liu, Xiaofeng and Hong, Yaying and Tang, Yuting and Yu, Yuzhong and Li, Haolin and Xie, Tao and Wang, Chong and Cai, Maoping and Qiu, Yang and Zeng, Xianzi and Peng, Tianming and Li, Qu and Li, Qianyi and Wu, Xingcheng and Song, Xian-Lu and Zhao, Shan-Chao},
title = {TGFβ-activated Asporin interacts with STMN1 to promote prostate cancer docetaxel chemoresistance and metastasis by upregulating the Wnt/β-catenin signaling pathway},
journal = {Drug Resistance Updates},
year = {2025},
doi = {10.1016/j.drup.2025.101227}
}
EUVIMED